IDR 1025.0
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 16.6 Million | 25.41 Million | 23.66 Million | 17.1 Million | 27.34 Million | 678.32 Thousand |
Net Income | 24.62 Million | 25.12 Million | 11.49 Million | -14.98 Million | 1.58 Million | -17.14 Million |
Depreciation & Amortization | 12.73 Million | 288.7 Thousand | 20.73 Million | 21.43 Million | 20.54 Million | 678.32 Thousand |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | -20.75 Million | -25.41 Million | -8.56 Million | 10.65 Million | 5.21 Million | 16.46 Million |
Investing Cash Flow | 14.53 Million | 24.73 Million | -5.9 Million | -9.58 Million | -3.16 Million | -26.13 Million |
Investments in PPE | -36.61 Million | -21.52 Million | -8.44 Million | -13.98 Million | -9.4 Million | -26.13 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 51.15 Million | 46.25 Million | 2.54 Million | 4.4 Million | 6.24 Million | - |
Financing Cash Flow | 16.48 Million | 2.18 Million | -25.71 Million | -12.57 Million | -21.01 Million | 12.53 Million |
Debt repayment | -3.13 Million | -1.77 Million | -30 Million | -18 Million | -3 Million | -2.4 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -1.07 Million | 3.96 Million | 4.28 Million | 5.42 Million | -18.01 Million | 14.94 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 100.69 Million | 27.24 Million | 35.19 Million | 40.24 Million | 40.01 Million | 34.56 Million |
Cash at end of period | 148.31 Million | 100.69 Million | 27.24 Million | 35.19 Million | 40.24 Million | 40.01 Million |
Capital Expenditure | -36.61 Million | -21.52 Million | -8.44 Million | -13.98 Million | -9.4 Million | -26.13 Million |
Effect of forex changes on cash | - | 21.11 Million | - | - | -2.93 Million | -186.19 Thousand |
Net cash flow / Change in cash | 47.62 Million | 73.45 Million | -7.94 Million | -5.05 Million | 232.21 Thousand | 5.44 Million |
Free Cash Flow | -20.01 Million | 3.89 Million | 15.21 Million | 3.11 Million | 17.94 Million | -25.46 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 5.36 Million | 2.65 Million | 24.62 Million | 9.72 Million | 4.26 Million | 5.28 Million |
Depreciation & Amortization | 2.28 Million | 2.56 Million | 12.73 Million | 2.73 Million | 2.8 Million | 3.6 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | 1.41 Million | -1.08 Million | -20.75 Million | -5.93 Million | -5.63 Million | -3.25 Million |
Investing Cash Flow | 12.03 Billion | 58.07 Billion | 14.53 Million | 2.58 Million | 6.66 Million | -1.76 Million |
Investments in PPE | -67.36 Billion | -8.1 Billion | -36.61 Million | -14.19 Million | -7.75 Million | -8.85 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 4.85 Million | -4.99 Million | 51.15 Million | 16.77 Million | 14.41 Million | 7.09 Million |
Financing Cash Flow | -36.2 Billion | -36.67 Billion | 16.48 Million | 15.17 Million | 3.41 Million | -1.08 Million |
Debt repayment | -26.67 Billion | -26.67 Billion | -3.13 Million | -1.14 Million | -661.97 Thousand | -666.99 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -533.42 Thousand | -581.17 Thousand | -1.07 Million | 144.71 Thousand | 4.07 Million | -419.41 Thousand |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 2373.4 Billion | 2286.42 Billion | 100.69 Million | 124.03 Million | 112.5 Million | 109.72 Million |
Cash at end of period | 2497.77 Billion | 2373.4 Billion | 148.31 Million | 148.31 Million | 124.03 Million | 112.5 Million |
Capital Expenditure | -67.36 Billion | -8.1 Billion | -36.61 Million | -14.19 Million | -7.75 Million | -8.85 Million |
Effect of forex changes on cash | - | - | - | - | - | -161.24 Thousand |
Net cash flow / Change in cash | 124.36 Billion | 86.98 Billion | 47.62 Million | 24.28 Million | 11.52 Million | 2.78 Million |
Free Cash Flow | -67.35 Billion | -8.1 Billion | -20.01 Million | -7.66 Million | -6.31 Million | -3.22 Million |
003003
3329
0JDO
ASTH
ALCOX
SBN